-
A Phase I Trial of Trebananib, an Angiopoietin 1 and 2 Neutralizing Peptibody, Combined with Pembrolizumab in Patients with Advanced Ovarian and Colorectal Cancer. Cancer Immunol Res. 2025 Jan 09; 13(1):9-22. View in:
Pubmed
-
Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response. JCO Precis Oncol. 2024 Dec; 8:e2400288. View in:
Pubmed
-
Clinical and Genomic Features of Classical and Basal Transcriptional Subtypes in Pancreatic Cancer. Clin Cancer Res. 2024 Nov 01; 30(21):4932-4942. View in:
Pubmed
-
Blockade of IL1ß and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor. Cancer Immunol Res. 2024 Sep 03; 12(9):1221-1235. View in:
Pubmed
-
Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered By Frequent Resistance. Curr Oncol Rep. 2024 Aug; 26(8):967-976. View in:
Pubmed
-
Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America. Am J Surg Pathol. 2024 Jul 01; 48(7):883-889. View in:
Pubmed
-
Author Correction: Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. NPJ Precis Oncol. 2024 May 06; 8(1):98. View in:
Pubmed
-
RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer. Clin Cancer Res. 2024 Apr 15; 30(8):1669-1684. View in:
Pubmed
-
Mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting. NPJ Precis Oncol. 2024 Apr 08; 8(1):87. View in:
Pubmed
-
Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders. J Immunother Cancer. 2024 01 25; 12(1). View in:
Pubmed
-
A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma. Clin Cancer Res. 2023 12 15; 29(24):5047-5056. View in:
Pubmed
-
Replicative stress in gastroesophageal cancer is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. iScience. 2023 Nov 17; 26(11):108169. View in:
Pubmed
-
Supportive learning environments, impression management and 'strategic imposterism': A word of caution. Med Educ. 2023 12; 57(12):1170-1172. View in:
Pubmed
-
Highly Sensitive Circulating Tumor DNA Assay Aids Clinical Management of Radiographically Occult Isolated Peritoneal Metastases in Patients With GI Cancer. JCO Precis Oncol. 2023 06; 7:e2200572. View in:
Pubmed
-
Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitors. bioRxiv. 2023 Mar 28. View in:
Pubmed
-
Reply to S. Chakrabarti and A. Mahipal. JCO Precis Oncol. 2023 03; 7:e2300043. View in:
Pubmed
-
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial. JAMA Netw Open. 2023 01 03; 6(1):e2249720. View in:
Pubmed
-
Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma. Cancers (Basel). 2022 Dec 16; 14(24). View in:
Pubmed
-
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers. JCO Precis Oncol. 2022 12; 6:e2200420. View in:
Pubmed
-
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma. NPJ Precis Oncol. 2022 Sep 02; 6(1):61. View in:
Pubmed
-
Early TP53 Alterations Shape Gastric and Esophageal Cancer Development. Cancers (Basel). 2021 Nov 24; 13(23). View in:
Pubmed
-
Opportunities for Utilization of DNA Repair Inhibitors in Homologous Recombination Repair-Deficient and Proficient Pancreatic Adenocarcinoma. Clin Cancer Res. 2021 12 15; 27(24):6622-6637. View in:
Pubmed
-
Coaching Versus Competency to Facilitate Professional Identity Formation. Acad Med. 2020 10; 95(10):1511-1514. View in:
Pubmed
-
Resident impression management within feedback conversations: A qualitative study. Med Educ. 2021 02; 55(2):266-274. View in:
Pubmed
-
Clinicopathological features and outcomes of fibrolamellar hepatocellular carcinoma. J Gastrointest Oncol. 2019 Jun; 10(3):554-561. View in:
Pubmed
-
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma. Clin Colorectal Cancer. 2019 09; 18(3):218-225. View in:
Pubmed
-
Local excision for patients with stage I anal canal squamous cell carcinoma can be curative. J Gastrointest Oncol. 2019 Apr; 10(2):171-178. View in:
Pubmed
-
Solid Pseudopapillary Neoplasms of the Pancreas: A Large American Cohort. Pancreas. 2019 04; 48(4):e21-e22. View in:
Pubmed
-
Survival and Prognostic Factors in Patients With Solid Pseudopapillary Neoplasms of the Pancreas. Pancreas. 2018 09; 47(8):1003-1007. View in:
Pubmed
-
Hepatotoxicity After Immune Checkpoint Inhibitor Therapy in Melanoma: Natural Progression and Management. Am J Clin Oncol. 2018 08; 41(8):760-765. View in:
Pubmed
-
Gastrointestinal Bleeding Secondary to Iliac Artery Pseudoaneurysm in a Patient With Remote Pancreas Transplant: A Case Report. Transplant Proc. 2018 Dec; 50(10):4087-4089. View in:
Pubmed
-
Feeling run down: exercise-induced pancytopenia. Br J Haematol. 2017 06; 177(5):672. View in:
Pubmed
-
Risk stratification using cytomorphologic features in endoscopic ultrasonographic-guided fine-needle aspiration diagnosis of pancreatic ductal adenocarcinoma. Diagn Cytopathol. 2015 Aug; 43(8):613-21. View in:
Pubmed
-
Occult pulmonary mucosa-associated lymphoid tissue lymphoma presenting as catastrophic antiphospholipid antibody syndrome. Oncol Lett. 2013 Nov; 6(5):1261-1264. View in:
Pubmed
